Andelyn Biosciences (“Andelyn”), a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (&ldqu...
Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., announced that The University of Alabama’s Culverhouse College of Business will continue it...
IntraBio Inc., a leader in the discovery, development, and commercialization of novel therapies for rare and common neurodegenerative diseases, announced...
NorahLux has launched the Red Light Therapy Research Hub, an interactive research tool designed to make studies on photobiomodulation easier to search an...
Cue Biopharma, a clinical-stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, announced positive topli...
Telix Pharmaceuticals Limited announces it has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE (“ITM”),...
XORTX Therapeutics Inc. (“XORTX” or the “Company”), a late-stage clinical pharmaceutical company focused on developing innov...
Silo Pharma (“Silo” or “the Company”), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug del...
Alpha Teknova, Inc. (“Teknova”), a leading producer of critical reagents for the discovery, development, and commercialization of novel thera...
As biologics and novel modalities become increasingly sophisticated, understanding molecular structure under controlled conditions tells only part ...
Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval...
If approved, Enspryng would be the first and only disease-modifying therapy for MOGAD (myelin oligodendrocyte glycoprotein antibody-associated diseas...
Approximately 600 patients expected to be enrolled at clinical sites across the United States, Europe, China and South America Global Phase 3 program, R...
FDA sets Prescription Drug User Fee Act (PDUFA) date of March 10, 2027 Positions lonvo-z to be the world’s first in vivo CRISPR-based therapy an...
© 2026 Biopharma Boardroom. All Rights Reserved.
